The proposed studies will examine how cocaine exposure affects AMPA receptor subunit (GluR) expression in the nucleus accumbens shell (NASh) and basolateral amygdala (BLA). The behavioral significance of changes in GluR expression in each region will be examined using state-of-the-art molecular methods (viral-mediated gene transfer) to directly modulate their expression. We will study the NASh because it mediates, at least in part, the rewarding effects of cocaine. We will study the BLA because it sends a direct glutamatergic projection to the NASh, and it is implicated in the development of cocaine sensitization. We have preliminary data showing that repeated intermittent exposure to cocaine regulates GluR expression in the BLA, and other investigators have shown cocaine regulation of GluRs in the nucleus accumbens as a whole.
In Aim 1, we will examine the effects of repeated intermittent cocaine (associated with behavioral sensitization) and continuous infusion of cocaine (associated with tolerance) on GluR expression in the BLA and NASh. Tissue will be examined at numerous time points following termination of drug treatment. To examine the pharmacological specificity of cocaine effects, we will conduct parallel studies with the selective dopamine reuptake inhibitor GBR 12909.
In Aim 2, we will use viral-mediated gene transfer to selectively alter expression of GluR1 and GluR2 in the BLA and NASh to examine the relevance of altered GluR expression on cocaine reward. In place conditioning experiments, we have preliminary data showing that increased expression of GluR2 in either region increases cocaine reward, whereas increased expression of GluR1 in either region decreases cocaine reward (and can make cocaine aversive).
In Aim 3, we will examine whether the effects of altered GluR expression on cocaine reward involve changes in the anxiety-related effects of the drug. We have preliminary data showing, in the BLA, that increased expression of GluR1 makes cocaine more anxiety-provoking, whereas increased expression of GluR2 makes cocaine less anxiety-provoking. Together, these studies provide a framework for future studies in which we will use additional behavioral and molecular techniques to explore mechanistic links between drug-induced neuroadaptations, reward, aversion, and anxiety. Understanding mechanistic links between cocaine-induced adaptations in gene expression and adaptations in behavior may facilitate the development of novel treatments for cocaine addiction and craving.

National Institute of Health (NIH)
National Institute on Drug Abuse (NIDA)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IFCN-1 (01))
Program Officer
Pilotte, Nancy S
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Mclean Hospital
United States
Zip Code
Myers, Karyn M; Bechtholt-Gompf, Anita J; Coleman, Brian R et al. (2012) Extinction of conditioned opiate withdrawal in rats in a two-chambered place conditioning apparatus. Nat Protoc 7:517-26
Myers, Karyn M; Carlezon Jr, William A; Davis, Michael (2011) Glutamate receptors in extinction and extinction-based therapies for psychiatric illness. Neuropsychopharmacology 36:274-93
Myers, Karyn M; Carlezon Jr, William A (2010) Extinction of drug- and withdrawal-paired cues in animal models: relevance to the treatment of addiction. Neurosci Biobehav Rev 35:285-302
Myers, Karyn M; Carlezon Jr, William A (2010) D-cycloserine facilitates extinction of naloxone-induced conditioned place aversion in morphine-dependent rats. Biol Psychiatry 67:85-7
Kenny, Paul J; Chartoff, Elena; Roberto, Marisa et al. (2009) NMDA receptors regulate nicotine-enhanced brain reward function and intravenous nicotine self-administration: role of the ventral tegmental area and central nucleus of the amygdala. Neuropsychopharmacology 34:266-81
Pereira Do Carmo, Gail; Stevenson, Glenn W; Carlezon, William A et al. (2009) Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior. Pain 144:170-7
Carlezon Jr, William A; Thomas, Mark J (2009) Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56 Suppl 1:122-32
Carlezon Jr, William A; Chartoff, Elena (2009) Perspective: Progress on the study and treatment of depressive illness. Neuropsychopharmacology 34:1361-2
Do Carmo, Gail Pereira; Folk, John E; Rice, Kenner C et al. (2009) The selective non-peptidic delta opioid agonist SNC80 does not facilitate intracranial self-stimulation in rats. Eur J Pharmacol 604:58-65
Chartoff, Elena H; Barhight, Matthew F; Mague, Steve D et al. (2009) Anatomically dissociable effects of dopamine D1 receptor agonists on reward and relief of withdrawal in morphine-dependent rats. Psychopharmacology (Berl) 204:227-39

Showing the most recent 10 out of 27 publications